Metrion Biosciences is a specialist contract research organisation serving the pharmaceutical and biotechnology sectors. It provides preclinical drug discovery services focused on ion channels, with expertise in electrophysiology, assay development, compound screening and pharmacology. Its services include ion channel screening, high-throughput screening, manual and automated patch clamp studies, cardiac safety profiling, neuroscience assays and integrated drug discovery support. The company works with clients from early hit identification through lead optimisation and candidate selection, generating robust data to help de-risk research programmes and support informed decisions in the development of new therapeutics.
